Immix Biopharma, Inc. - Common Stock — Cash Flow (NASDAQ:IMMX) | MetaTrader

Open full chart Full chart

Financials

Overview Statement Statistics

Quarterly Annual

Cash from operating activities -1.59 M-7.41 M-11.37 M-14.6 M-23.93 M -32.07 M Cash from investing activities -8020-52.09 K-1.18 M-7.21 M -11.95 M Cash from financing activities 18.85 M3.23 M15.46 M15.95 M107.39 M 107.35 M Free cash flow -1.59 M-7.41 M-11.37 M-14.6 M-24.66 M -32.77 M

News

Wall Street Analysts See a 120.59% Upside in Immix Biopharma (IMMX): Can the Stock Really Move This High?

Citizens initiates Immix Biopharma stock coverage with outperform rating

Immix Biopharma stock climbs after FDA grants breakthrough therapy status

FDA grants breakthrough therapy status to ImmixBio’s amyloidosis drug

Immix Biopharma (IMMX) Shares Slip As Investors Focus On Plans To Offer And Sell $750 Million In Securities - Immix Biopharma (NASDAQ:IMMX)

Immix Biopharma: Thesis Playing Out; Thoughts On Valuation And Competition (IMMX)

Immix Biopharma CFO Gabriel Morris buys $5k in shares

Ilya Rachman, Immix Biopharma CEO, buys $4975 in shares

Immix Biopharma stock price target raised to $12 from $8 at H.C. Wainwright

Immix Biopharma closes $93.7 million public offering

Immix Biopharma prices $100 million public offering to fund AL amyloidosis drug

Immix Biopharma reports 75% complete response rate for NXC-201